Summary
The following efficacy summary describes the Curio Platform offerings for maternal mental health. Curio Digital Therapeutics has developed an AI-driven predictive tool to identify and risk-stratify members at risk for developing postpartum depression. Combined with neurobehavioral interventions, the Curio Platform affords an opportunity for plans to reduce costs while improving the quality of care. Efficacy summaries for Curio’s MamaLift and MamaLift Plus neurobehavioral interventions are described.